Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01183923 · ClinicalTrials.gov registry record · NA

Dietary Interventions in Asthma Treatment: Sprouts Study

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT01183923: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT01183923 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01183923, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

Sulforaphane (SFN) is a naturally occurring isothiocyanate that is a potent inducer of Phase II enzymes which play a critical role in preventing oxidative stress (via activation of Nrf2). Broccoli sprouts (BS) contain the richest source of SFN. The main objectives of this study are to test the effect of broccoli sprouts (BS) on biomarkers of oxidative stress (OS), inflammation, basophil activation, and clinical outcomes in mouse allergen-induced asthma by (1) determining if BS improves lung function and airways symptom responses in mouse-sensitized adults with asthma undergoing environmental mouse allergen challenge (EMAC), (2) examining the effect of BS on OS, inflammation, and basophil activation, and (3) examining the effect of BS on changes in OS, inflammation, and basophil activation after EMAC.

Interventions

  • OTHER Broccoli Sprouts
  • OTHER Alfalfa Sprouts

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2010-11
Est. Completion 2012-02-06
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01183923

The ClinicalTrials.gov registry entry for NCT01183923 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Broccoli Sprouts is the first listed.

NCT01183923 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01183923 about?

NCT01183923 is a clinical study titled "Dietary Interventions in Asthma Treatment: Sprouts Study". Sulforaphane (SFN) is a naturally occurring isothiocyanate that is a potent inducer of Phase II enzymes which play a critical role in preventing oxidative stress (via activation of Nrf2). Broccoli sprouts (BS) contain the richest source of SFN. The main objectives of this study are to test the effe...

What is the current status of trial NCT01183923?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-11. Estimated completion is 2012-02-06.

What interventions are being tested in trial NCT01183923?

The interventions under investigation include: Broccoli Sprouts (OTHER), Alfalfa Sprouts (OTHER).

Who is sponsoring clinical trial NCT01183923?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.